Codes / ICD10CM / Q60

Q60 Renal agenesis and other reduction defects of kidney

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Renal agenesis and other reduction defects of kidney

Summary

Renal agenesis and other reduction defects of the kidney are congenital conditions characterized by the partial or complete absence or underdevelopment of one or both kidneys. These defects arise during fetal development and can range from unilateral renal agenesis (absence of one kidney) to bilateral renal agenesis (absence of both kidneys), which is incompatible with life. Other reduction defects may include hypoplastic kidneys (small, underdeveloped kidneys) or dysplastic kidneys (abnormal tissue development). The severity of the condition depends on the extent of renal involvement and associated urinary tract abnormalities.

Causes

These defects are primarily caused by disruptions in normal kidney development during embryogenesis. While specific causes are often not identifiable, genetic factors and environmental influences are commonly implicated. Mutations in genes involved in renal development, such as those regulating ureteric bud formation or nephron induction, may contribute. Maternal factors, including exposure to teratogens or certain medications during pregnancy, can also increase risk, though the exact mechanisms remain under investigation.

Risk Factors

  • Family history of congenital kidney defects.
  • Genetic syndromes associated with renal anomalies (e.g., Potter sequence).
  • Maternal exposure to substances that disrupt fetal development.
  • Pre-existing maternal health conditions affecting fetal organogenesis.

Symptoms

  • Absence of one or both kidneys (unilateral or bilateral renal agenesis).
  • Underdeveloped kidneys (hypoplasia) or abnormal kidney tissue (dysplasia).
  • Associated urinary tract abnormalities, such as ureteral or bladder defects.
  • Oligohydramnios (low amniotic fluid) in severe cases, leading to pulmonary hypoplasia.
  • Incompatible with life in bilateral renal agenesis due to lack of fetal urine production.

Diagnosis

Prenatal diagnosis is often achieved through ultrasound, which may detect absent or small kidneys, oligohydramnios, or associated anomalies. Postnatal confirmation may involve imaging studies like renal ultrasound, MRI, or CT scans to assess kidney structure and function. Laboratory tests, including serum creatinine and urine analysis, may be used to evaluate renal function. Genetic testing may be considered if a syndromic cause is suspected.

Treatment Options

Treatment depends on the severity and associated complications. Unilateral renal agenesis typically requires monitoring for kidney function and blood pressure, as the remaining kidney may compensate. Bilateral renal agenesis is fatal, and management focuses on palliative care. Hypoplastic or dysplastic kidneys may require surgical intervention for associated anomalies (e.g., ureteral obstruction) or renal replacement therapy (dialysis) if function is severely impaired. Long-term follow-up with a nephrologist is essential.

Prognosis and Follow-Up

Prognosis varies based on the extent of renal involvement. Unilateral renal agenesis often has a good prognosis with normal life expectancy, though lifelong monitoring for hypertension or renal function decline is recommended. Bilateral renal agenesis is incompatible with life. Hypoplastic or dysplastic kidneys may lead to chronic kidney disease, requiring regular follow-up to manage complications. Early detection and intervention improve outcomes for associated anomalies.

Complications

  • Chronic kidney disease or renal failure (in bilateral or severe unilateral cases).
  • Hypertension due to reduced renal mass.
  • Urinary tract infections or obstructions.
  • Pulmonary hypoplasia (in bilateral cases with oligohydramnios).
  • Growth retardation or developmental delays (if renal function is severely impaired).

Lifestyle & Prevention

  • Prenatal care, including folic acid supplementation, may reduce risk of congenital anomalies.
  • Avoid exposure to teratogens (e.g., alcohol, certain medications) during pregnancy.
  • Genetic counseling for families with a history of renal defects.
  • Regular monitoring of blood pressure and kidney function in affected individuals.

When to Seek Professional Help

Seek medical attention if prenatal ultrasound suggests renal anomalies, or if postnatal symptoms like poor urine output, swelling, or developmental delays occur. Immediate evaluation is critical for bilateral renal agenesis or severe reduction defects to manage complications and plan care.

Tips for Medical Coders

When coding for renal agenesis and other reduction defects of the kidney (ICD-10-CM code Q60), ensure documentation specifies the type (e.g., unilateral, bilateral, hypoplastic) and any associated anomalies. Code Q60 includes congenital absence or underdevelopment of the kidney, but additional codes may be required for related conditions (e.g., oligohydramnios, Potter sequence). Verify specificity in clinical notes to support accurate coding.

Book a walkthrough

Q60 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.